S. Coughlin

Publications222
h-index91
Citations34,739
Highly Influential Citations1,504
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • B. Kobilka
  • 539 Publications • 64,087 Citations
  • L. Brass
  • 266 Publications • 19,531 Citations
  • C. Esmon
  • 503 Publications • 42,300 Citations
  • J. Fenton
  • 237 Publications • 11,357 Citations
  • Publications
  • Influence
Thrombin signalling and protease-activated receptors
TLDR
Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development.
View on Springer
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
View on Elsevier
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
  • S. Coughlin
  • Biology
    Journal of thrombosis and haemostasis : JTH
  • 1 August 2005
TLDR
Roles for PARs in blood vessel formation and other processes during embryonic development are emerging, and whether these reflect new roles for the coagulation cascade and/or PAR signaling to other proteases remains to be explored.
View on Wiley
A dual thrombin receptor system for platelet activation
TLDR
It is reported that thrombin responses in platelets from PAR3-deficient mice were markedly delayed and diminished but not absent, and the identification of a two-receptor system for platelet activation byThrombin has important implications for the development of antithrombotic therapies.
View on Nature
Protease-activated receptor 3 is a second thrombin receptor in humans
TLDR
Cl cloning and characterization of a new human thrombin receptor, designated protease-activated receptor 3 (PAR3) is reported, which can mediate throm-bin-triggered phosphoinositide hydrolysis and is expressed in a variety of tissues, making it a candidate for the sought-after second platelet throm bin receptor.
View on Springer
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
TLDR
Observations suggest that PAR1 and PAR4 account for most, if not all, thrombin signaling in platelets and that antagonists that block these receptors might be useful antithrombotic agents.
View on PubMed
Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
TLDR
Separate sources provide S1P to plasma and lymph to help lymphocytes exit the low-S1P environment of lymphoid organs, and disruption of compartmentalized S 1P signaling is a plausible mechanism by which S1p-receptor-1 agonists function as immunosuppressives.
View on Publisher
PAR3 is a cofactor for PAR4 activation by thrombin
Identification of the mechanisms by which the coagulation protease thrombin activates platelets is critical for understanding haemostasis and thrombosis. Thrombin activates cells at least in part by…
View on Nature
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
TLDR
The results suggest that PAR2, although not activatable by thrombin, may nonetheless function as a sensor for coagulation proteases and contribute to endothelial activation in the setting of injury and inflammation.
View on PubMed
Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.
TLDR
The identification of the MCP-1 receptor and cloning of two distinct isoforms provide powerful tools for understanding the specificity and signaling mechanisms of this important chemokine.
View on PubMed
...
...